These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28530267)

  • 21. Effect of lanthanide complex structure on cell viability and association.
    Peterson KL; Dang JV; Weitz EA; Lewandowski C; Pierre VC
    Inorg Chem; 2014 Jun; 53(12):6013-21. PubMed ID: 24901440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A time-resolved luminescence biosensor assay for anaplastic lymphoma kinase (ALK) activity.
    Cui W; Parker LL
    Chem Commun (Camb); 2015; 51(2):362-5. PubMed ID: 25406835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a terbium complex-based luminescent probe for imaging endogenous hydrogen peroxide generation in plant tissues.
    Ye Z; Chen J; Wang G; Yuan J
    Anal Chem; 2011 Jun; 83(11):4163-9. PubMed ID: 21548628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence selective dual-emission detection of (i, i + 1) bis-phosphorylated peptide using diazastilbene-type Zn(II)-Dpa chemosensor.
    Ishida Y; Inoue MA; Inoue T; Ojida A; Hamachi I
    Chem Commun (Camb); 2009 May; (20):2848-50. PubMed ID: 19436886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft.
    Raub TJ; Wishart GN; Kulanthaivel P; Staton BA; Ajamie RT; Sawada GA; Gelbert LM; Shannon HE; Sanchez-Martinez C; De Dios A
    Drug Metab Dispos; 2015 Sep; 43(9):1360-71. PubMed ID: 26149830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
    Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K
    Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First bodipy-DOTA derivatives as probes for bimodal imaging.
    Bernhard C; Goze C; Rousselin Y; Denat F
    Chem Commun (Camb); 2010 Nov; 46(43):8267-9. PubMed ID: 20877903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.
    Josan JS; De Silva CR; Yoo B; Lynch RM; Pagel MD; Vagner J; Hruby VJ
    Methods Mol Biol; 2011; 716():89-126. PubMed ID: 21318902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A highly luminescent and highly oxygen-sensitive Tb(III) complex with a tris-aryloxide functionalised 1,4,7-triazacyclononane ligand.
    Nakai H; Goto T; Kitagawa K; Nonaka K; Matsumoto T; Ogo S
    Chem Commun (Camb); 2014 Dec; 50(99):15737-9. PubMed ID: 25364794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle inhibitors make progress.
    Brower V
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006194
    [No Abstract]   [Full Text] [Related]  

  • 31. CDK4/6 blockade in breast cancer: current experience and future perspectives.
    Zardavas D; Pondé N; Tryfonidis K
    Expert Opin Investig Drugs; 2017 Dec; 26(12):1357-1372. PubMed ID: 29027483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-resolved probes and oxidase-based biosensors using terbium(III)-guanosine monophosphate-mercury(II) coordination polymer nanoparticles.
    Zhang M; Qu ZB; Han CM; Lu LF; Li YY; Zhou T; Shi G
    Chem Commun (Camb); 2014 Nov; 50(85):12855-8. PubMed ID: 25208485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cyclin-dependent kinases 4 and 6 in breast cancer.
    Mayer EL
    Clin Adv Hematol Oncol; 2015 Apr; 13(4):215-7. PubMed ID: 26352578
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficient luminescence from fluorene- and spirobifluorene-based lanthanide complexes upon near-visible irradiation.
    Bottaro G; Rizzo F; Cavazzini M; Armelao L; Quici S
    Chemistry; 2014 Apr; 20(16):4598-607. PubMed ID: 24668801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes.
    Morris MC
    Cell Biochem Biophys; 2010; 56(1):19-37. PubMed ID: 19921468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA approves Novartis's CDK4/6 inhibitor.
    Mullard A
    Nat Rev Drug Discov; 2017 Mar; 16(4):229. PubMed ID: 28356596
    [No Abstract]   [Full Text] [Related]  

  • 37. Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.
    Kuil J; Steunenberg P; Chin PT; Oldenburg J; Jalink K; Velders AH; van Leeuwen FW
    Chembiochem; 2011 Aug; 12(12):1897-903. PubMed ID: 21739561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charge-transfer-based terbium MOF nanoparticles as fluorescent pH sensor for extreme acidity.
    Qi Z; Chen Y
    Biosens Bioelectron; 2017 Jan; 87():236-241. PubMed ID: 27566397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature.
    Knudsen ES; Hutcheson J; Vail P; Witkiewicz AK
    Oncotarget; 2017 Jul; 8(27):43678-43691. PubMed ID: 28620137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A luminescent affinity tag for proteins based on the terbium(III)-binding peptide.
    Sueda S; Tanaka S; Inoue S; Komatsu H
    Anal Biochem; 2012 Mar; 422(1):52-4. PubMed ID: 22266297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.